Maryland HB808 prohibits the Maryland Medical Assistance Program from using step therapy or fail-first protocols for certain mental health drugs.

Maryland HB808 amends the Maryland Medical Assistance Program to prohibit the use of step therapy or fail-first protocols for prescription drugs treating serious mental illnesses, including bipolar disorder, schizophrenia, major depression, post-traumatic stress disorder, and medication-induced movement disorders. The bill also mandates prior authorization for these drugs starting July 1, 2026. This change aims to ensure timely access to necessary treatments for enrolled adults with these diagnoses.

Maryland HB808 prohibits the Maryland Medical Assistance Program from using step therapy or fail-first protocols for certain mental health drugs.

Maryland HB808 amends the Maryland Medical Assistance Program to prohibit the use of step therapy or fail-first protocols for prescription drugs treating serious mental illnesses, including bipolar disorder, schizophrenia, major depression, post-traumatic stress disorder, and medication-induced movement disorders. The bill also mandates prior authorization for these drugs starting July 1, 2026. This change aims to ensure timely access to necessary treatments for enrolled adults with these diagnoses.